{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T22:09:11Z","timestamp":1774994951048,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,11]],"date-time":"2018-03-11T00:00:00Z","timestamp":1520726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13256-018-1612-4","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T06:01:45Z","timestamp":1519884105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature"],"prefix":"10.1186","volume":"12","author":[{"given":"Khadega A.","family":"Abuelgasim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hinna","family":"Rehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Alsubaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasser","family":"Al Atwi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Al Balwi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Alshieban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areej","family":"Almughairi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,11]]},"reference":[{"key":"1612_CR1","unstructured":"National Institutes of Health, National Cancer Institute. Cancer Stat Facts. \n                    https:\/\/seer.cancer.gov\/statfacts\/html\/clyl.html\n                    \n                  . Accessed 2 Nov 2017."},{"key":"1612_CR2","doi-asserted-by":"publisher","unstructured":"Ammann EM, Shanafelt TD, Wright KB, McDowell BD, Link BK, Chrischillies EA. Updating survival estimates in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL\/SLL) based on treatment-free interval. Leuk Lymphoma. 2017; \n                    https:\/\/doi.org\/10.1080\/10428194","DOI":"10.1080\/10428194"},{"key":"1612_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/cncr.11520","volume":"98","author":"G Garcia-Manero","year":"2003","unstructured":"Garcia-Manero G, Faderl S, O\u2019Brien S, Cortes J, Talpez M, Kantarjan HM. Chronic myelogenous leukemia: a review and update of therapeutic strategies. Cancer. 2003;98:437\u201357.","journal-title":"Cancer."},{"key":"1612_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cancergencyto.2003.11.015","volume":"152","author":"H Chang","year":"2004","unstructured":"Chang H, Sutherland R, Nayar R, Li D, Kamel-Reid S, Mile MA, et al. Chronic lymphocytic leukemia in the course of chronic myelocytic leukemia: evidence of independent clonal origin as shown by interphase fluorescence in situ hybridization and fluorescence activated cell sorting. Cancer Genet Cytogenet. 2004;152:146\u20138.","journal-title":"Cancer Genet Cytogenet."},{"key":"1612_CR5","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1080\/1042819031000063435","volume":"44","author":"V Mansat-De Mas","year":"2003","unstructured":"Mansat-De Mas V, Rigal-Huquet F, Cassar G, Kuhlein E, Laurent G, Dastugue N. Chronic myeloid leukemia associated with B-cell chronic lymphocytic leukemia: evidence of two separate clones as shown by combined cell-sorting and fluorescence in situ hybridisation. Leuk Lymphoma. 2003;44:867\u20139.","journal-title":"Leuk Lymphoma."},{"key":"1612_CR6","first-page":"1145","volume":"56","author":"BSN CrisanAM","year":"2015","unstructured":"CrisanAM BSN, Jardan C, Vasilache ED, Dobera C, Gheorghe A, et al. The occurrence of chronic lymphocytic leukemia after chronic phase of chronic myeloid leukemia: case report and literature review. Rom J Morph Embrol. 2015;56:1145\u201351.","journal-title":"Rom J Morph Embrol."},{"key":"1612_CR7","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/ajh.22171","volume":"86","author":"L Laurenti","year":"2011","unstructured":"Laurenti L, Tarnani M, Nichele I, Clolli S, Cortelezzi A, Forconi F, et al. The coexistence of chronic lymphocytic leukemia and myeloproliferative neoplasms: a retrospective multicenteric GIMEMA experience. Am J Hematol. 2011;86:1007\u201312.","journal-title":"Am J Hematol."},{"key":"1612_CR8","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.7754\/Clin.Lab.2014.140315","volume":"60","author":"B Fattizzo","year":"2014","unstructured":"Fattizzo B, Radice T, Cattaneo D, Pomati M, Barcellini W, Iurol A. Three hematologic malignancies in the same patient: chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemia. Clin Lab. 2014;60:1929\u201332.","journal-title":"Clin Lab."},{"key":"1612_CR9","first-page":"596","volume":"82","author":"J Esteve","year":"1997","unstructured":"Esteve J, Cervantes F, Rives S, Rozman M, Zarco MA, Montserrat E. Simultaneous occurrence of B-cell chronic lymphocytic leukemia and chronic myeloid leukemia with further evolution to lymphoid blast crisis. Haematologica. 1997;82:596\u20139.","journal-title":"Haematologica."},{"key":"1612_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1053\/j.seminoncol.2006.01.016","volume":"33","author":"AM Tsimberidou","year":"2006","unstructured":"Tsimberidou AM, Keating MJ. Richter\u2019s transformation in CLL. Semin Oncol. 2006;33:250\u20136.","journal-title":"Semin Oncol."},{"key":"1612_CR11","first-page":"1146","volume":"26","author":"P Jain","year":"2012","unstructured":"Jain P, O\u2019Brien S. Richter\u2019s transformation in chronic lymphocytic leukemia. Oncology (Williston Park). 2012;26:1146\u201352.","journal-title":"Oncology (Williston Park)."},{"key":"1612_CR12","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s11899-014-0223-4","volume":"9","author":"SA Parikh","year":"2014","unstructured":"Parikh SA, Shanafelt TD. Risk factors for Richter syndrome in chronic lymphocytic leukemia. Curr Hematol Malig Rep. 2014;9:294\u20139.","journal-title":"Curr Hematol Malig Rep."},{"key":"1612_CR13","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1365-2141.2007.06801.x","volume":"139","author":"K Maddocks-Christianson","year":"2007","unstructured":"Maddocks-Christianson K, Slager SL, Zent CS, Reinaida M, Call TG, Habermann TM, et al. Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukemia. Br J Haematol. 2007;139:398\u2013404.","journal-title":"Br J Haematol."},{"key":"1612_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/cncr.20773","volume":"103","author":"AM Tsimberidou","year":"2005","unstructured":"Tsimberidou AM, Keating MJ. Richter syndrome: biology, incidence, and therapeutic strategies. Cancer. 2005;103:216\u201328.","journal-title":"Cancer."},{"key":"1612_CR15","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/bjh.12458","volume":"162","author":"SA Parikh","year":"2013","unstructured":"Parikh SA, Rabe KG, Call TG, Zent CS, Habermann TM, Ding W, et al. Diffuse Large B-Cell Lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients. Br J Haematol. 2013;162:774\u201382.","journal-title":"Br J Haematol."},{"issue":"1","key":"1612_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clml.2016.08.021","volume":"17","author":"EC Ayers","year":"2017","unstructured":"Ayers EC, Mato AR. Richter\u2019s Transformation in the Era of Kinase Inhibitor Therapy: A Review. Clin Lymphoma Myeloma Leuk. 2017;17(1):1\u20136.","journal-title":"Clin Lymphoma Myeloma Leuk."},{"key":"1612_CR17","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1200\/JCO.1999.17.8.2454","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Vena DA, Barrett J, Freidin B. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphocytic leukaemias. J Clin Oncol. 1999;17:2454\u201360.","journal-title":"J Clin Oncol."},{"key":"1612_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/ajcp\/104.2.199","volume":"104","author":"RK Brynes","year":"1995","unstructured":"Brynes RK, McCourty A, Sun NC, Koo CH. Trisomy 12 in Richter\u2019s transformation of chronic lymphocytic leukemia. Am J Clin Pathol. 1995;104:199\u2013203.","journal-title":"Am J Clin Pathol."},{"key":"1612_CR19","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/sj.leu.2402529","volume":"16","author":"F Cobo","year":"2002","unstructured":"Cobo F, Martinez A, Pinyol M, Hernandez L. Multiple cell cycle regulator alterations in Richter\u2019s transformation of chronic lymphocytic leukemia. Leukemia. 2002;16:1028\u201334.","journal-title":"Leukemia."},{"key":"1612_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/bjh.13346","volume":"169","author":"N Gunnarsson","year":"2015","unstructured":"Gunnarsson N, Stenke L, Hoglund M, Sandin F, Bjorkholm M, Dreimane A, et al. Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era. Br J Haematol. 2015;169:683\u20138.","journal-title":"Br J Haematol."},{"key":"1612_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.leukres.2007.07.023","volume":"32","author":"M Breccia","year":"2008","unstructured":"Breccia M, Martelli M, Cannella L, Russo E, Finolezzi E, Stefanizzi C, et al. Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukemia and relapsed non-Hodgkin lymphoma. Leuk Res. 2008;32:353\u20135.","journal-title":"Leuk Res."},{"key":"1612_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0165-4608(98)00116-2","volume":"108","author":"H Acar","year":"1999","unstructured":"Acar H, Ecirli S, Gundogan F, Bullay O, Acar A. Simultaneous occurrence of chronic myelogenous leukemia and non-Hodgkin lymphoma at diagnosis. Cancer Genet Cytogenet. 1999;108:171\u20134.","journal-title":"Cancer Genet Cytogenet."},{"key":"1612_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/10428190290006288","volume":"43","author":"A Zamecnikova","year":"2002","unstructured":"Zamecnikova A, Vranovsky A, Hlvcak P. Coexistance of Philadelphia-positive chronic granulocytic leukemia and diffuse large B-cell lymphoma at initial diagnosis. Leuk Lymphoma. 2002;43:429\u201331.","journal-title":"Leuk Lymphoma."},{"key":"1612_CR24","first-page":"1","volume":"4","author":"R Louis","year":"2016","unstructured":"Louis R, Gupta SK, Jain S, Mehta A, Agarwal M. Therapy related Chronic Myeloid Leukemia (trCML) on non-Therapy Related Second Malignancy Chronic Myeloid Leukemia (smCML) following Diffuse Large B-Cell Lymphoma (DLBCL): A Case Report and review of Literature. Am J Cancer Case Rep. 2016;4:1\u20139.","journal-title":"Am J Cancer Case Rep."},{"key":"1612_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/sj.leu.2401606","volume":"14","author":"R Ichinohasama","year":"2000","unstructured":"Ichinohasama R, Miura I, Takahashi N, Sugawara T, Tamate E, Endoh K, et al. Ph-negative non-Hodgkin\u2019s lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature. Leukemia. 2000;14:169\u201382.","journal-title":"Leukemia."}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1612-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-018-1612-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1612-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,10]],"date-time":"2019-03-10T20:02:55Z","timestamp":1552248175000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-018-1612-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,11]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1612"],"URL":"https:\/\/doi.org\/10.1186\/s13256-018-1612-4","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,11]]},"assertion":[{"value":"30 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"The need for approval was waived by King Abdullah International Research Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"64"}}